OUR VISION A WORLD FREE FROM DEATH AND SUFFERING CAUSED BY FUNGAL DISEASE.

Our Board Members

are the driving force behind GAFFI’s mission. They bring a wealth of expertises in global health and senior management posts.

Patrick Francioli

BIOGRAPHY >

Yasuaki Mori

BIOGRAPHY >

Juan Luis Rodríguez Tudela MD PhD

BIOGRAPHY >

Oddi Aasheim

BIOGRAPHY >

Biography:

Patrick Francioli studied Medicine in Lausanne and undertook several missions for the International Committee of the Red Cross in Bangladesh, South Vietnam, Iran and Indonesia. He did postgraduate training in Internal Medicine and Infectious Diseases Laboratory in Lausanne and several internships in American universities. He was appointed Chief Physician in hospital epidemiology/Infection Control at the CHUV in Lausanne and full professor in 1994. From 2000 to 2006, he was head of the Infectious Diseases Department, and from 2006-2012 was Dean of the Faculty of Biology and Medicine at the University of Lausanne, from which he has now retired.

Patrick Francioli has been internationally recognised for his expertise and his research work in the field of hospital infections, infectious endocarditis, Lyme disease and AIDS. He contributed to the influence of Swiss research as President of the Swiss HIV Cohort Study for 16 years. He has published more than 400 scientific articles. He was one of the founders of Swissnoso, a Swiss expert group dedicated to the reduction of nosocomial infections and multi-resistant microorganisms. He led the Programme Committee for Europe’s premier infectious disease meeting (ECCMID) for many years.

No potential conflicts of interest.

Former Board members are:
Jorge Alvar (2013-2015), David Denning (2013-2018), Michel Glauser (2013-2020), Victor Rydgren (2013-2021) and Nigel Lightfoot (2013-2021).

Biography:

Yasuaki Mori joined Infineon Technologies Japan K.K. as President in November 2000 and is a member of the executive management group.  Before joining Infineon, he moved to Japan in 1997 and became the head of sales & marketing for Advanced Micro Devices Japan.  Prior to this he was based in Europe and the US in various positions including business development, marketing, lobbying and strategy.
Born in Canada, raised in Switzerland, Yasuaki Mori earned a Bachelor of Science in Electrical Engineering with specialization in digital communications in 1983 and a Masters in International Affairs in 1984 from Columbia University in New York City.  He is fluent in English, Japanese and French and also speaks German.

He is member of the Association of Japanese Corporate Executives (Keizai Doyoukai), German Chamber of Commerce, American Chamber of Commerce and ACCJ Growth Strategy Task Force where he contributed to policy papers for the Japanese government.

Yasuaki Mori is a Swiss Board member and a Trustee of GAFFI, UK.

No potential conflicts of interest.

Former Board members are:
Jorge Alvar (2013-2015), David Denning (2013-2018), Michel Glauser (2013-2020), Victor Rydgren (2013-2021) and Nigel Lightfoot (2013-2021).

Biography:

Juan Luis Rodríguez Tudela MD PhD was born in Madrid in 1958. He gained his MD from Complutense University of Madrid. He is a Specialist in Clinical Microbiology and studied for his PhD at the Autonomous University de Madrid.

Juan Luis was the founder of the medical Mycology Reference Laboratory of Spain at the National Centre for Microbiology of Instituto de Salud Carlos III. He served as Director National Centre for Microbiology of Instituto de Salud Carlos III from 2000 to 2003. His last position at National Centre for Microbiology of Instituto de Salud Carlos III was as Director of the Department of Bacteriology, Mycology and Parasitology. He has run a variety of research projects and scientific activities focused on fungal infections afflicting humans, early diagnosis of invasive fungal infections, standardization of antifungal susceptibility testing, resistance mechanisms, and taxonomy of fungal species.

Juan Luis has published over 230 original articles

Juan Luis has served as member of several international associations, ex-Chairman of the Steering Committee of the Antifungal Subcommittee of Antifungal Susceptibility Testing of the European Committee of Antimicrobial Susceptibility Testing (AFST-EUCAST) and advisor of the PAHO on the Antifungal Resistance Surveillance Network in Latin-America. He or members of its laboratory have run several workshops focused in diagnosis and resistance detection of fungi in different countries of American continent as Argentina, Brazil, Chile, Colombia, Cuba, and Mexico.

Juan Luis is a minority shareholder in next Level Diagnostics (Ukraine) and sits on the Board of 2 charitable foundations.

Former Board members are:
Jorge Alvar (2013-2015), David Denning (2013-2018), Michel Glauser (2013-2020), Victor Rydgren (2013-2021) and Nigel Lightfoot (2013-2021).

Biography:

Oddi Aasheim is the founder and Managing Director of FirstHuman, a company that specialises in the facilitation and implementation of performance breakthroughs and in breakthrough leadership.  Prior to FirstHuman, Oddi has been the Commercial Director for JMW Worldwide UK, a Strategy Executive for Accenture and Transformation Manager for Shell UK.

Oddi was born in Norway, but moved to the UK when he did his B.Eng. in Offshore Civil Engineering at Heriot-Watt University.  He has remained close to his alma mater and held positions such as Member of the Heriot-Watt Foundation Board, been the President of the London Watt-Club, had a seat at the Watt-Club Council,  and sat on the General Convocation.  Currently he is also a board member of the Norwegian YWCA in the UK.

Oddi is a Swiss Board member and a Trustee of GAFFI, UK.

There are no conflicts of interest.

Former Board members are:
Jorge Alvar (2013-2015), David Denning (2013-2018), Michel Glauser (2013-2020), Victor Rydgren (2013-2021) and Nigel Lightfoot (2013-2021).